Top

Published in:

Open Access 01-12-2016 | Research article

A randomized controlled trial of smoking cessation methods in patients newly-diagnosed with pulmonary tuberculosis

Authors: Mahshid Aryanpur, Mostafa Hosseini, Mohammad Reza Masjedi, Esmaeil Mortaz, Payam Tabarsi, Hamid Soori, Habib Emami, Gholamreza Heidari, Mehdi Kazempour Dizagie, Masoud Baikpour

Published in: BMC Infectious Diseases | Issue 1/2016

Abstract

Background

Tuberculosis (TB) and tobacco use are two major alarming global health issues that tend to be co-prevalent in many developing countries and various surveys have provided evidence on their entangled associations. Accordingly, it is strongly suggested that smoking cessation be incorporated in TB control programs. Therefore, we aimed to evaluate the effectiveness of two smoking cessation methods among newly-diagnosed pulmonary TB patients.

Methods

A total of 210 newly-diagnosed pulmonary TB patients from Tehran, Iran with smoking habits were included in this randomized clinical trial during 2012–2013. Patients were assigned to three groups of control (just TB medical treatment), brief advice (TB medical treatment plus individualized counseling sessions of quitting behavioral therapy) and combined intervention (TB medical treatment plus individualized counseling sessions of quitting behavioral therapy plus medical treatment with slow release bupropion). Patients’ abstinence was followed at six time point during six months. Data were analyzed by SPSS v.22 using Generalized Estimating Equations (GEE) model.

Results

Abstinance rate at the end of six months were 71.7 % for combined intervention group, 33.9 % for brief advice group and 9.8 % for the control group (p < 0.001). Combined intervention group and brief advice group respectively had 35 times (p < 0.001, OR = 35.26, 95 % CI = 13.77–90.32) and 7 times (p < 0.001, OR = 7.14, 95 % CI = 2.72–18.72) more odds of not being an active smoker at each time point, compared to the control group.

Conclusion

Considering the prevalence and importance of TB and the substantial influence of these preventive measures on controlling tobacco use, application of such programs is recommended.

Trial registration

The survey was registered in the Iranian registry of clinical trials website (irct.ir) in August 31, 2013 with IRCT ID: IRCT2013062613783N1.

Organization WH. Global tuberculosis control: WHO report 2010. World Health Organization; 2010. http://apps.who.int/iris/bitstream/10665/44425/1/9789241564069_eng.pdf.

Organization WH. WHO global report on trends in prevalence of tobacco smoking 2015. 2015. http://apps.who.int/iris/bitstream/10665/156262/1/9789241564922_eng.pdf.

Pai M, Mohan A, Dheda K, Leung CC, Yew WW, Christopher DJ, Sharma SK. Lethal interaction: the colliding epidemics of tobacco and tuberculosis. 2007. http://apps.who.int/iris/bitstream/10665/156262/1/9789241564922_eng.pdf.

Siddiqi K, Lee ACK. An integrated approach to treat tobacco addiction in countries with high tuberculosis incidence. Trop Med Int Health. 2009;14(4):420–8.CrossRefPubMed

Organization WH. A WHO/The Union monograph on TB and tobacco control: joining efforts to control two related global epidemics. Geneva: WHO; 2007.

Thomas A, Gopi P, Santha T, Chandrasekaran V, Subramani R, Selvakumar N, Eusuff S, Sadacharam K, Narayanan P. Predictors of relapse among pulmonary tuberculosis patients treated in a DOTS programme in South India. Int J Tuberc Lung Dis. 2005;9(5):556–61.PubMed

Maciel E, Brioschi A, Peres R, Guidoni L, Ribeiro F, Hadad D, Vinhas S, Zandonade E, Palaci M, Dietze R. Smoking and 2-month culture conversion during anti-tuberculosis treatment. Int J Tuberc Lung Dis. 2013;17(2):225–8.CrossRefPubMedPubMedCentral

Godoy P, Cayla J, Carmona G, Camps N, Alvarez J, Alsedà M, Minguell S, Rodés A, Altet N, Pina J. Smoking in tuberculosis patients increases the risk of infection in their contacts. Int J Tuberc Lung Dis. 2013;17(6):771–6.CrossRefPubMed

d’Arc Lyra Batista J, de Alencar Ximenes R, Rodrigues L. Smoking increases the risk of relapse after successful tuberculosis treatment. Int J Epidemiol. 2008;37(4):841–51.CrossRefPubMedPubMedCentral

10.

Jiang J, Liu B, Nasca P, Zeng X, Chen J, Zou X, Wu Y, Han W, Zhao P, Li J. Smoking and risk of death due to pulmonary tuberculosis: a case-control comparison in 103 population centers in China. Int J Tuberc Lung Dis. 2009;13(12):1530–5.PubMed

11.

Gajalakshmi V, Peto R, Kanaka TS, Jha P. Smoking and mortality from tuberculosis and other diseases in India: retrospective study of 43 000 adult male deaths and 35 000 controls. Lancet. 2003;362(9383):507–15.CrossRefPubMed

12.

Lienhardt C, Fielding K, Sillah J, Bah B, Gustafson P, Warndorff D, Palayew M, Lisse I, Donkor S, Diallo S. Investigation of the risk factors for tuberculosis: a case–control study in three countries in West Africa. Int J Epidemiol. 2005;34(4):914–23.CrossRefPubMed

13.

Novotny TE. Smoking cessation and tuberculosis: connecting the DOTS [Editorial]. Int J Tuberc Lung Dis. 2008;12(10):1103.PubMed

14.

Awaisu A, Nik Mohamed MH, Abd Aziz N, Syed Sulaiman SA, Mohamad Noordin N, Muttalif AR, Ahmad Mahayiddin A. Tobacco use prevalence, knowledge, and attitudes among newly diagnosed tuberculosis patients in Penang State and Wilayah Persekutuan Kuala Lumpur, Malaysia. Tob Induc Dis. 2010;8(1):3.CrossRefPubMedPubMedCentral

15.

Wang J, Shen H. Review of cigarette smoking and tuberculosis in China: intervention is needed for smoking cessation among tuberculosis patients. BMC Public Health. 2009;9(1):292.CrossRefPubMedPubMedCentral

16.

Hersey P, Prendergast D, Edwards A. Effects of cigarette smoking on the immune system. Follow-up studies in normal subjects after cessation of smoking. Med J Aust. 1983;2(9):425–9.PubMed

17.

Hughes D, Haslam P, Townsend P, Turner-Warwick M. Numerical and functional alterations in circulatory lymphocytes in cigarette smokers. Clin Exp Immunol. 1985;61(2):459.PubMedPubMedCentral

18.

Arcavi L, Benowitz NL. Cigarette smoking and infection. Arch Intern Med. 2004;164(20):2206–16.CrossRefPubMed

19.

Miller LG, Goldstein G, Murphy M, Ginns LC. Reversible alterations in immunoregulatory T cells in smoking. Analysis by monoclonal antibodies and flow cytometry. Chest J. 1982;82(5):526–9.CrossRef

20.

El Sony A, Slama K, Salieh M, Elhaj H, Adam K, Hassan A, Enarson D. Feasibility of brief tobacco cessation advice for tuberculosis patients: a study from Sudan. Int J Tuberc Lung Dis. 2007;11(2):150–5.PubMed

21.

Slama K, Chiang C, Enarson D. Tobacco cessation and brief advice [Educational Series: tobacco and tuberculosis. Serialised guide. Tobacco cessation interventions for tuberculosis patients. Number 4 in the series]. Int J Tuberc Lung Dis. 2007;11(6):612–6.PubMed

22.

Chiang C, Slama K, Enarson D. Associations between tobacco and tuberculosis [Educational Series: tobacco and tuberculosis. Serialised guide. Tobacco cessation interventions for tuberculosis patients. Number 1 in the series]. Int J Tuberc Lung Dis. 2007;11(3):258–62.PubMed

23.

Awaisu A, Nik Mohamed MH, Mohamad Noordin N, Abd Aziz N, Syed Sulaiman SA, Muttalif R, Ahmed Mahayiddin M. The SCIDOTS project: evidence of benefits of an integrated tobacco cessation intervention in tuberculosis care on treatment outcomes. Subst Abuse Treat Prev Policy. 2011;6(1):26.CrossRefPubMedPubMedCentral

24.

Siddiqi K, Khan A, Ahmad M, Dogar O, Kanaan M, Newell JN, Thomson H. Action to stop smoking in suspected tuberculosis (ASSIST) in Pakistan: a cluster randomized, controlled trial. Ann Intern Med. 2013;158(9):667–75.CrossRefPubMed

25.

Siddiquea B, Islam M, Bam T, Satyanarayana S, Enarson D, Reid A, Husain MA, Ahmed S, Ferdous S, Ishikawa N. High quit rate among smokers with tuberculosis in a modified smoking cessation programme in Dhaka, Bangladesh. Public Health Action. 2013;3(3):243–6.CrossRefPubMedPubMedCentral

26.

Slama K, Chiang C-Y, Enarson DA. Tobacco cessation interventions for tuberculosis patients: a guide for low-income countries: Int J Tuberc Lung Dis. 2008. https://www.ghdonline.org/uploads/Tobacco-and-TB-Guide.pdf.

27.

Organization WH. Treatment of tuberculosis: guidelines for national programmes, vol. 61. Geneva: World Health Organization; 2003.

28.

Jarvis MJ, Tunstall-Pedoe H, Feyerabend C, Vesey C, Saloojee Y. Comparison of tests used to distinguish smokers from nonsmokers. Am J Public Health. 1987;77(11):1435–8.CrossRefPubMedPubMedCentral

29.

Basu S, Stuckler D, Bitton A, Glantz SA. Projected effects of tobacco smoking on worldwide tuberculosis control: mathematical modelling analysis. BMJ. 2011;343:d5506.CrossRefPubMedPubMedCentral

30.

Campbell I, Chaudhary R, Holdsworth G, Lyne O. Brief advice to tuberculosis patients in Nepal to stop smoking: a pilot study by the Britain Nepal Medical Trust. Int J Tuberc Lung Dis. 2014;18(12):1438–42.CrossRefPubMed

31.

Stead LF, Bergson G, Lancaster T. Physician advice for smoking cessation. Cochrane Database Syst Rev. 2008;2(2):CD000165.PubMed

32.

Ng N, Padmawati R, Prabandari Y, Nichter M. Smoking behavior among former tuberculosis patients in Indonesia: intervention is needed. Int J Tuberc Lung Dis. 2008;12(5):567–72.PubMed

33.

Pradeepkumar A, Thankappan K, Nichter M. Smoking among tuberculosis patients in Kerala, India: proactive cessation efforts are urgently needed. Int J Tuberc Lung Dis. 2008;12(10):1139–45.PubMed

34.

Shin SS, Xiao D, Cao M, Wang C, Li Q, Chai W, Lindsay R, Usita P, Novotny T. Patient and doctor perspectives on incorporating smoking cessation into tuberculosis care in Beijing, China. Int J Tuberc Lung Dis. 2012;16(1):126–31.CrossRefPubMed

35.

Meysamie A, Ghaletaki R, Zhand N, Abbasi M. Cigarette smoking in Iran. Iran J Public Health. 2012;41(2):1.PubMedPubMedCentral

Title: A randomized controlled trial of smoking cessation methods in patients newly-diagnosed with pulmonary tuberculosis
Authors: Mahshid Aryanpur
Mostafa Hosseini
Mohammad Reza Masjedi
Esmaeil Mortaz
Payam Tabarsi
Hamid Soori
Habib Emami
Gholamreza Heidari
Mehdi Kazempour Dizagie
Masoud Baikpour
Publication date: 01-12-2016
Publisher: BioMed Central
Published in: BMC Infectious Diseases / Issue 1/2016
Electronic ISSN: 1471-2334
DOI: https://doi.org/10.1186/s12879-016-1727-4

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

A randomized controlled trial of smoking cessation methods in patients newly-diagnosed with pulmonary tuberculosis

Abstract

Background

Methods

Results

Conclusion

Trial registration

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Trial registration

Please log in to get access to this content

Other articles of this Issue 1/2016

Relation between BCG vaccine scar and an interferon-gamma release assay in immigrant children with “positive” tuberculin skin test (≥10 mm)

Do piperacillin/tazobactam and other antibiotics with inhibitory activity against Clostridium difficile reduce the risk for acquisition of C. difficile colonization?

The interaction between artemether-lumefantrine and lopinavir/ritonavir-based antiretroviral therapy in HIV-1 infected patients

Population seroprevalence of antibody to influenza A(H7N9) virus, Guangzhou, China

Epidemiology and RAPD-PCR typing of thermophilic campylobacters from children under five years and chickens in Morogoro Municipality, Tanzania

Characterization of Sarcoptes scabiei cofilin gene and assessment of recombinant cofilin protein as an antigen in indirect-ELISA for diagnosis

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page